Overview
Kentaro Jingushi practices in Osaka, Japan. Mr. Jingushi is rated as an Advanced expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Bladder Cancer.
His clinical research consists of co-authoring 45 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles in the study of Renal Cell Carcinoma (RCC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Renal Cell Carcinoma (RCC)Mr. Jingushi isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Urothelial CancerMr. Jingushi isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Bladder CancerMr. Jingushi isExperienced. Learn about Bladder Cancer.
- Lung CancerMr. Jingushi isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Jingushi isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Prostate CancerMr. Jingushi isExperienced. Learn about Prostate Cancer.
- Upper Tract Urothelial Carcinoma (UTUC)Mr. Jingushi isExperienced. Learn about Upper Tract Urothelial Carcinoma (UTUC).